I have seen some posts about Leo and Menon and high salaries being the reason they are trying to build CTIX and that Leo and Menon don't care about shareholders. I don't buy it. These two have worked extremely hard to get to this point. Putting together trials and getting all of the locations set up as well as the QA/QC and legal documents and all the lab work followed by making sure the drug is provided to each location and then analyzing data and getting appropriate approvals is a lot. Finding and hiring staff and then preparing PRs when something needs to be shared. All of that is a lot of work not to mention the R&D for all of the indications and various forms (e.g., kevetrin oral dose). I think they could find good paying positions in the medical field without as much hassle based upon their backgrounds. They are building CTIX for much more than the salaries they currently take. start-up biotechs are risky and they both know that...but I think they believe in their drugs and think they can be successful... I am not going anywhere until I see the results of these Phase II trials.